Skip to content

Surgical Treatment of Long Bone Metastases

Surgical Treatment for Long Bone Metastases With Intramedullary Nail or Endoprosthetic Reconstruction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03188926
Acronym
MTC
Enrollment
120
Registered
2017-06-16
Start date
2016-01-04
Completion date
2020-01-31
Last updated
2020-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Metastases, Surgery

Brief summary

To provide treatment guidelines for patients with long bone metastatic disease based on observational study and to propose an algorithm to guide orthopedic surgeons in decision-making for these patient.

Detailed description

The objectives of this study were to examine clinical outcomes after reconstruction with intramedullary fixation (IMN) or endoprosthetic reconstruction (EPR) with a specific focus on (1) the rate of complication or failure; (2) differences in complication rates by anatomic site; (3) functional results as assessed by the Musculoskeletal Tumor Society System (MSTS); (4) differences in complication rate between patients treated with INM versus EPR; and (5) differences in survival in patients with metastatic bone disease based on disease-specific, laboratory, and demographic information.

Interventions

Surgical treatment of impending or pathologic fracture in the extremities

Sponsors

Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* bone metastases of the extremity

Exclusion criteria

* bone metastases of the spine

Design outcomes

Primary

MeasureTime frameDescription
Clinical outcomes after treatment of long bone metastases with intramedullary nail versus endoprosthetic reconstruction1 yearThe objectives of this study were to examine clinical outcomes after reconstruction with intramedullary nail versus endoprosthetic reconstruction with a specific focus on differences in complication rate between patients treated with intramedullary nail versus endoprosthetic reconstruction

Secondary

MeasureTime frameDescription
Survival in patients undergoing surgery for metastatic bone disease1 yearProvide a reliable and objective means of estimating survival in patients with metastatic bone disease based on disease-specific

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026